2UZE

Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor

Summary for 2UZE

Related1E9H 1FIN 1FVV 1GY3 1H1P 1H1Q 1H1R 1H1S 1H24 1H25 1H26 1H27 1H28 1JST 1JSU 1OGU 1OI9 1OIU 1OIY 1OKV 1OKW 1OL1 1OL2 1P5E 1PKD 1QMZ 1URC 1VYW 2BKZ 2BPM 2C4G 2C5N 2C5O 2C5P 2C5T 2C5V 2C5X 2C6T 2CCH 2CCI 2CJM 2IW6 2IW8 2IW9 2UUE 2UZB 2UZD 2UZL 2UZN 2UZO
DescriptorCELL DIVISION PROTEIN KINASE 2, CYCLIN A2, 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID, ... (4 entities in total)
Functional Keywordstransferase, atp-binding, phosphorylation, cdk2, kinase, cyclin, mitosis, cell cycle, cell division, nucleotide-binding, serine/threonine-protein kinase, thiazolidinone ligand
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains4
Total molecular weight127990.16
Authors
Richardson, C.M.,Dokurno, P.,Murray, J.B.,Surgenor, A.E. (deposition date: 2007-04-27, release date: 2007-06-26, Last modification date: 2019-04-03)
Primary citation
Richardson, C.M.,Nunns, C.L.,Williamson, D.S.,Parratt, M.J.,Dokurno, P.,Howes, R.,Borgognoni, J.,Drysdale, M.J.,Finch, H.,Hubbard, R.E.,Jackson, P.S.,Kierstan, P.,Lentzen, G.,Moore, J.D.,Murray, J.B.,Simmonite, H.,Surgenor, A.E.,Torrance, C.J.
Discovery of a Potent Cdk2 Inhibitor with a Novel Binding Mode, Using Virtual Screening and Initial, Structure-Guided Lead Scoping.
Bioorg.Med.Chem.Lett., 17:3880-, 2007
PubMed: 17570665 (PDB entries with the same primary citation)
DOI: 10.1016/J.BMCL.2007.04.110
MImport into Mendeley
Experimental method
X-RAY DIFFRACTION (2.4 Å)
?

Structure validation

RfreeClashscoreRamachandran outliersSidechain outliersRSRZ outliers 0.2369 0.8% 8.6% 4.2%MetricValuePercentile RanksWorseBetterPercentile relative to all X-ray structuresPercentile relative to X-ray structures of similar resolution
Download full validation report